• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新生儿期先天性溶血性贫血的严重表现:诊断与治疗问题

Severe Presentation of Congenital Hemolytic Anemias in the Neonatal Age: Diagnostic and Therapeutic Issues.

作者信息

Cortesi Valeria, Manzoni Francesca, Raffaeli Genny, Cavallaro Giacomo, Fattizzo Bruno, Amelio Giacomo Simeone, Gulden Silvia, Amodeo Ilaria, Giannotta Juri Alessandro, Mosca Fabio, Ghirardello Stefano

机构信息

Department of Clinical Sciences and Community Health, Università degli Studi di Milano, 20122 Milan, Italy.

Neonatal Intensive Care Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

出版信息

Diagnostics (Basel). 2021 Aug 26;11(9):1549. doi: 10.3390/diagnostics11091549.

DOI:10.3390/diagnostics11091549
PMID:34573891
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8467765/
Abstract

Congenital hemolytic anemias (CHAs) are a group of diseases characterized by premature destruction of erythrocytes as a consequence of intrinsic red blood cells abnormalities. Suggestive features of CHAs are anemia and hemolysis, with high reticulocyte count, unconjugated hyperbilirubinemia, increased lactate dehydrogenase (LDH), and reduced haptoglobin. The peripheral blood smear can help the differential diagnosis. In this review, we discuss the clinical management of severe CHAs presenting early on in the neonatal period. Appropriate knowledge and a high index of suspicion are crucial for a timely differential diagnosis and management. Here, we provide an overview of the most common conditions, such as glucose-6-phosphate dehydrogenase deficiency, pyruvate kinase deficiency, and hereditary spherocytosis. Although rare, congenital dyserythropoietic anemias are included as they may be suspected in early life, while hemoglobinopathies will not be discussed, as they usually manifest at a later age, when fetal hemoglobin (HbF) is replaced by the adult form (HbA).

摘要

先天性溶血性贫血(CHAs)是一组由于内在红细胞异常导致红细胞过早破坏为特征的疾病。CHAs的提示性特征为贫血和溶血,伴有高网织红细胞计数、非结合性高胆红素血症、乳酸脱氢酶(LDH)升高和触珠蛋白降低。外周血涂片有助于鉴别诊断。在本综述中,我们讨论了新生儿期早期出现的重度CHAs的临床管理。适当的知识和高度的怀疑指数对于及时进行鉴别诊断和管理至关重要。在此,我们概述了最常见的情况,如葡萄糖-6-磷酸脱氢酶缺乏症、丙酮酸激酶缺乏症和遗传性球形红细胞增多症。虽然先天性红细胞生成异常性贫血罕见,但因其可能在生命早期被怀疑,故也包括在内,而血红蛋白病将不做讨论,因为它们通常在胎儿血红蛋白(HbF)被成人形式(HbA)取代的较晚年龄才表现出来。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ecb/8467765/ad1921c5e3ef/diagnostics-11-01549-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ecb/8467765/ad1921c5e3ef/diagnostics-11-01549-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ecb/8467765/ad1921c5e3ef/diagnostics-11-01549-g001.jpg

相似文献

1
Severe Presentation of Congenital Hemolytic Anemias in the Neonatal Age: Diagnostic and Therapeutic Issues.新生儿期先天性溶血性贫血的严重表现:诊断与治疗问题
Diagnostics (Basel). 2021 Aug 26;11(9):1549. doi: 10.3390/diagnostics11091549.
2
Confounding factors in the diagnosis and clinical course of rare congenital hemolytic anemias.罕见先天性溶血性贫血的诊断和临床病程中的混杂因素。
Orphanet J Rare Dis. 2021 Oct 9;16(1):415. doi: 10.1186/s13023-021-02036-4.
3
Hemolytic anemia.溶血性贫血
Am Fam Physician. 2004 Jun 1;69(11):2599-606.
4
Congenital Hemolytic Anemias: Is There a Role for the Immune System?先天性溶血性贫血:免疫系统是否发挥作用?
Front Immunol. 2020 Jun 23;11:1309. doi: 10.3389/fimmu.2020.01309. eCollection 2020.
5
Laboratory Approach to Hemolytic Anemia.溶血性贫血的实验室检查方法。
Indian J Pediatr. 2020 Jan;87(1):66-74. doi: 10.1007/s12098-019-03119-8. Epub 2019 Dec 10.
6
Congenital Hemolytic Anemia.先天性溶血性贫血。
Med Clin North Am. 2017 Mar;101(2):361-374. doi: 10.1016/j.mcna.2016.09.008. Epub 2016 Dec 8.
7
Use of Laser Assisted Optical Rotational Cell Analyzer (LoRRca MaxSis) in the Diagnosis of RBC Membrane Disorders, Enzyme Defects, and Congenital Dyserythropoietic Anemias: A Monocentric Study on 202 Patients.激光辅助光学旋转细胞分析仪(LoRRca MaxSis)在红细胞膜疾病、酶缺陷及先天性红细胞生成异常性贫血诊断中的应用:一项对202例患者的单中心研究
Front Physiol. 2018 Apr 27;9:451. doi: 10.3389/fphys.2018.00451. eCollection 2018.
8
[Hereditary enzyme defects of erythrocytes: glucose-6-phosphate dehydrogenase deficiency and pyruvate kinase deficiency].[红细胞的遗传性酶缺陷:葡萄糖-6-磷酸脱氢酶缺乏症和丙酮酸激酶缺乏症]
Ther Umsch. 2006 Jan;63(1):47-56. doi: 10.1024/0040-5930.63.1.47.
9
Rare Hereditary Hemolytic Anemias: Diagnostic Approach and Considerations in Management.罕见遗传性溶血性贫血:诊断方法及治疗注意事项。
Hematol Oncol Clin North Am. 2019 Jun;33(3):373-392. doi: 10.1016/j.hoc.2019.01.002. Epub 2019 Mar 29.
10
The affinity glycated hemoglobin in a family with hereditary spherocytosis and in other non-hemoglobinopathic hemolytic anemias.遗传性球形红细胞增多症家族及其他非血红蛋白病性溶血性贫血中的亲和糖化血红蛋白。
Ann Clin Lab Sci. 1987 Sep-Oct;17(5):331-8.

引用本文的文献

1
Neonatal Hemolytic Jaundice: Causes, Diagnostic Approach, and Management.新生儿溶血性黄疸:病因、诊断方法及治疗
Children (Basel). 2025 May 23;12(6):666. doi: 10.3390/children12060666.
2
Neonatal hereditary spherocytosis: a case report.新生儿遗传性球形红细胞增多症:一例报告
Ital J Pediatr. 2025 Jun 17;51(1):193. doi: 10.1186/s13052-025-02049-w.
3
Risk of low levels of blood group antibodies mediating hemolysis in ABO-incompatible neonates with negative three hemolysis tests.三项溶血试验均为阴性的ABO血型不相容新生儿中,介导溶血的血型抗体水平低的风险

本文引用的文献

1
Genetics and Genomics Approaches for Diagnosis and Research Into Hereditary Anemias.遗传性贫血诊断与研究的遗传学和基因组学方法
Front Physiol. 2020 Dec 22;11:613559. doi: 10.3389/fphys.2020.613559. eCollection 2020.
2
Glucose-6-Phosphate Dehydrogenase Deficiency and the Benefits of Early Screening.葡萄糖-6-磷酸脱氢酶缺乏症与早期筛查的益处。
Neonatal Netw. 2020 Aug 1;39(5):270-282. doi: 10.1891/0730-0832.39.5.270.
3
Congenital dyserythropoietic anemias.先天性红细胞生成异常性贫血。
Front Pediatr. 2024 Aug 5;12:1392308. doi: 10.3389/fped.2024.1392308. eCollection 2024.
4
Current Status of Molecular Diagnosis of Hereditary Hemolytic Anemia in Korea.韩国遗传性溶血性贫血的分子诊断现状。
J Korean Med Sci. 2024 May 13;39(18):e162. doi: 10.3346/jkms.2024.39.e162.
5
Clinical value of combined predictors of RET%, γ-GT, LDH in the ABO neonatal hemolytic disease.RET%、γ-GT、LDH联合预测指标在ABO新生儿溶血病中的临床价值
Front Pediatr. 2023 Dec 1;11:1265739. doi: 10.3389/fped.2023.1265739. eCollection 2023.
6
The application value of mean red blood cell volume and red blood cell volume distribution width combined with total serum bilirubin in the early screening of neonatal hemolytic disease.平均红细胞体积和红细胞体积分布宽度联合总胆红素在新生儿溶血病早期筛查中的应用价值。
BMC Pediatr. 2023 Jan 13;23(1):19. doi: 10.1186/s12887-022-03812-2.
7
Korean clinical practice guidelines for the diagnosis of hereditary hemolytic anemia.韩国遗传性溶血性贫血诊断临床实践指南。
Blood Res. 2022 Jun 30;57(2):86-94. doi: 10.5045/br.2022.2021224. Epub 2022 May 20.
8
Identification of a Novel Mutation of β-Spectrin in Hereditary Spherocytosis Using Whole Exome Sequencing.应用全外显子组测序鉴定遗传性球形红细胞增多症中的一种新型β- spectrin 突变。
Int J Mol Sci. 2021 Oct 12;22(20):11007. doi: 10.3390/ijms222011007.
Blood. 2020 Sep 10;136(11):1274-1283. doi: 10.1182/blood.2019000948.
4
Management of pyruvate kinase deficiency in children and adults.儿童和成人丙酮酸激酶缺乏症的管理。
Blood. 2020 Sep 10;136(11):1241-1249. doi: 10.1182/blood.2019000945.
5
Congenital Hemolytic Anemias: Is There a Role for the Immune System?先天性溶血性贫血:免疫系统是否发挥作用?
Front Immunol. 2020 Jun 23;11:1309. doi: 10.3389/fimmu.2020.01309. eCollection 2020.
6
Prevalence of pyruvate kinase deficiency: A systematic literature review.丙酮酸激酶缺乏症的患病率:系统文献回顾。
Eur J Haematol. 2020 Aug;105(2):173-184. doi: 10.1111/ejh.13424. Epub 2020 Jun 23.
7
Genotype-phenotype correlation and molecular heterogeneity in pyruvate kinase deficiency.丙酮酸激酶缺乏症的基因型-表型相关性和分子异质性。
Am J Hematol. 2020 May;95(5):472-482. doi: 10.1002/ajh.25753. Epub 2020 Mar 6.
8
Laboratory diagnosis of G6PD deficiency. A British Society for Haematology Guideline.葡萄糖-6-磷酸脱氢酶(G6PD)缺乏症的实验室诊断。英国血液学学会指南。
Br J Haematol. 2020 Apr;189(1):24-38. doi: 10.1111/bjh.16366. Epub 2020 Jan 28.
9
AG-348 (Mitapivat), an allosteric activator of red blood cell pyruvate kinase, increases enzymatic activity, protein stability, and ATP levels over a broad range of PKLR genotypes.AG-348(Mitapivat)是一种红血球丙酮酸激酶的别构激活剂,能够在广泛的 PKLR 基因型范围内提高酶活性、蛋白稳定性和 ATP 水平。
Haematologica. 2021 Jan 1;106(1):238-249. doi: 10.3324/haematol.2019.238865.
10
Updated Worldwide Epidemiology of Inherited Erythrocyte Disorders.遗传性红细胞疾病的全球最新流行病学。
Acta Haematol. 2020;143(3):196-203. doi: 10.1159/000502434. Epub 2019 Sep 24.